Newbury Pharmaceuticals

Rwanda
Byumba, Northern Province, Rwanda, 223 81

Company profile

Newbury Pharmaceuticals company profile

​Newbury Pharmaceuticals is a hybrid pharmaceutical company specializing in specialty prescription drugs, innovation, and brands within the Scandinavian market. The company's portfolio focuses on therapeutic areas such as oncology, rare diseases, and neurology. The company offers both proprietary and licensed products, aiming to provide treatment solutions that contribute positively to the healthcare system and patient well-being. ​

Business identity

Contact email
[email protected]
Phone number
+46 46 12 11 20
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2020-01-01, Year

Headquarters

Postal code
223 81
Country code
RW
Continent
Africa

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
1
Total equity funding
$1.8M
Last funding
Post IPO Equity / $1.8M / 2024-03-04
Last equity funding
Post IPO Equity / $1.8M
Founders
1
Articles
4
Exited on
2022-02-04

Categories and groups

Founders and investors

Founders

Karl Karlsson